SEC Form 4 · accession 0001415889-17-001861
INNOVUS PHARMACEUTICALS, INC. · INNV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henry Jemil Esber
Director
Period of report
Nov 23, 2017
Accepted (ET)
Nov 27, 2017 · 7:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 23, 2017 | P | 90,000 | $0.0926 | A | 90,000 | D | |
| Common Stock | Nov 23, 2017 | P | 5,000 | $0.094 | A | 95,000 | D | |
| Common Stock | Nov 23, 2017 | P | 5,000 | $0.0976 | A | 100,000 | D |
Table II — derivative securities
No Table II lines on this filing.